We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes & Acquisition of Deferred Shares

30 Sep 2020 07:00

RNS Number : 5056A
Path Investments plc
30 September 2020
 

Path Investments plc

("Path" or the "Company")

Board Changes

 

Acquisition of Deferred Shares

 

 

Path Investments plc (TIDM: PATH), the energy and natural resources investment company, is pleased announce certain changes to the Company's Board.

 

Board Changes

 

Director appointments

 

Path announces two new appointments to the Board. Mr Allardyce is being appointed with immediate effect and it is proposed that Mr Tulloch will join the Board on readmission of Path's ordinary shares to trading on the London Stock Exchange.

 

John ("Jack") Allardyce, Executive Director

 

Jack has over 15 years' experience in natural resources, including 10 years as a leading oil and gas equity research analyst with a number of UK investment banks. He began his career as a process engineer working on North Sea projects, before joining the leading research and consultancy house Wood Mackenzie, specialising in European upstream and unconventionals. Jack's skillset spans global asset evaluation, financial forecasting, petroleum economics, corporate advisory, M&A and equity capital markets. He graduated from Heriot-Watt University with a degree in Chemical Engineering. 

 

Nicholas Tulloch, Proposed Non-Executive Director

 

Nick Tulloch has advised companies on the UK capital markets for over 20 years, working for several well-known investment banks and stockbrokers, including Cazenove, Arbuthnot, KBR and Cantor Fitzgerald. With a particular focus on oil and gas, Nick has worked on cross-border transactions in many parts of the world. In 2019 he became Finance Director and then subsequently CEO of Zoetic International plc transforming the company from its oil and gas roots to become the first vertically integrated CBD company to be listed in London. Nick began his career as a solicitor with Gouldens and he holds a master's degree in law from Oxford University. Nick stood for parliament in 2017.

 

Director resignation

Path announces that after four years as a Non-Executive Director of the Company, Tommaso Corrado has resigned from the Board with immediate effect in order to focus on his other business commitments.

Commenting on the changes, Christopher Theis, CEO of Path said: "We are delighted to welcome both Nick and Jack to the Board. They both bring valuable experience of DTU, our forthcoming acquisition, to Path and shall play an important part in monetising the technology.

"We are sorry to be bidding farewell to Tommaso and would like to thank him for his hard work and commitment to the Company and wish him great success in his future ventures."

 

Acquisition of Deferred Shares

 

In accordance with Article 3.4(iii) of the Company's Articles of Association, the Company will acquire the Deferred Shares of £0.039 nominal value per Deferred Share for no consideration with effect from 5.00 pm today and will then cancel all Deferred Shares after which no Deferred Shares will remain in issue.

 

Listing Rule 9.6.13 disclosures

 

Other than Nick Tulloch's previous role as a director of Zoetic International plc, Path confirms that there are no further disclosures to be made in respect of either Jack Allardyce or Nick Tulloch for the purposes of Listing Rule 9.6.13.

 

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

IFC Advisory Limited (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

Grant Thornton UK LLP (Financial Adviser)

Samantha Harrison

020 7865 2411

Harrison Clarke

020 7184 4384

Keith, Bayley, Rogers & Co. Limited (Broker)

Brinsley Holman

07776 30 22 28

Graham Atthill-Beck

07506 43 41 07

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDCIXDDGGC
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.